Message #10 From:
NewsBot Date: November 14, 2005 02:00:00 AM
ACET News Aceto to Present at CSFB Health Care Conference
LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--Nov. 14, 2005--Aceto Corporation (NASDAQ:ACET), a global distributor of chemically-derived pharmaceuticals, biopharmaceuticals, specialty chemicals and agrochemicals, today announced that Leonard S. Schwartz, Chairman, CEO and President, will present at Credit Suisse First Boston's Health Care Conference in Phoenix, Arizona on Wednesday, November 16, 2005 at approximately 1:00 p.m. ET.
The audio/visual presentation will be broadcast live over the Internet via the Events page of the Investor Relations section of the Company's website at www.aceto.com. Interested parties are advised to go to the site at least 15 minutes early to register, download and install any necessary audio software. If unable to listen live, the presentation will be archived.
ABOUT ACETO
Aceto Corporation, which was incorporated in 1947, is a global leader in the distribution and marketing of biopharmaceuticals, chemically-derived pharmaceuticals, specialty chemicals and agrochemicals used principally as raw materials in the agricultural, color, pharmaceutical, surface coating/ink and general chemical consuming industries. With offices in ten countries, Aceto distributes over 1,000 chemicals in these and other fields.
This presentation referenced in this news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on current expectations, estimates and projections of management. Aceto intends for these forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. The forward-looking statements contained in this press release include, but are not limited to, statements regarding emergence of a market for human generic biopharmaceuticals, approval of applications for, and sales of, veterinary vaccines, results for the second quarter of fiscal year 2006, and prospects for long-term growth. All forward-looking statements in this press release are made as of the date of this press release, and Aceto assumes no obligation to update these forward-looking statements whether as a result of new information, future events or otherwise, other than as required by law. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. These uncertainties include, but are not limited to, the mix of products sold and the profit margins thereon, order cancellation or a reduction in orders from customers, competitive product offerings and pricing actions, the availability and pricing of key raw materials, dependence on key members of management, risk of entering into new European markets, continued successful integration of acquisitions, economic and political conditions in the United States and abroad, as well as other risks detailed in the Company's SEC reports, including the Company's Form 10-K and other filings. Copies of these filings are available at www.sec.gov.
